Company news

Perseus Proteomics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Non-consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP)

August 13, 2026

Notice Regarding the Results of a Clinical Study in Patients Who Participated in the Phase I Clinical Trial of PPMX-T003 for Polycythemia Vera

July 1, 2026

(Amendments) Amendments to “Non-consolidated Summary of Financial Results for the Fiscal Year Ended March 31, 2026”

June 21, 2026

Non-consolidated Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2023

August 12, 2022

Notice on Determination of Stock Option (Share acquisition rights) Details

July 11, 2022

Notice on Issuance of Stock Option (Share acquisition rights)

June 23, 2022

(Amendments) Amendments to “Non-consolidated Summary of Financial Results for the Fiscal Year Ended March 31, 2022

June 23, 2022

Notice on Booking of Non-operating Income, Non-operating Expenses, Extraordinary Income and Extraordinary Loss

February 14, 2022

Decks